Skip to main content
FCHS
OTC Industrial Applications And Services

First Choice Healthcare Reports $8.4M Loss, Going Concern Doubt, and Details of SPAC Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$0.008
Mkt Cap
$273.554K
52W Low
$0.002
52W High
$0.51
52W Position info
453% above low
Off High info
98% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

FCHS has more than doubled off its 52-week low of $0.002 on light trading volume (0.1× avg).

Summary

First Choice Healthcare's 10-Q shows deepening losses, a near-zero cash balance, and a going concern warning, while also revealing the terms of a debt-to-equity conversion and the full acquisition agreement for its SPAC merger.


Key Events · Earnings and Guidance · FCHS

  • Net Loss Widens to $8.4M

    For the six months ended June 30, 2026, net loss attributable to common shareholders was $8,447,243, compared to $2,037,329 in the prior year period, driven by a $7.4 million interest expense from debt conversions.

  • Going Concern Warning

    The company states substantial doubt about its ability to continue as a going concern, with a working capital deficit and cash of only $6,842 as of June 30, 2026.

  • Debt Converted to Preferred Stock

    $22,242,837 of debt was converted into Series C Preferred Stock, and Series E Preferred Stock was issued with a 15% dividend and a conversion price at a 20% discount to the lowest closing price after 12 months, creating significant future dilution risk.

  • SPAC Merger Details Disclosed

    The 10-Q includes the Amended and Restated Stock Purchase Agreement for the acquisition of Pointe Med Entities, with a maximum purchase price of $21,306,000, to be completed concurrently with the Westin Acquisition Corp. business combination.


Analysis · FCHS · Industrial Applications And Services

The 10-Q reveals a net loss of $8.4 million for the first half of 2026, a cash balance of just $6,842, and a going concern warning. It also details the conversion of $22.2 million of debt into preferred stock with highly dilutive terms, including a 20% discount conversion price for Series E. The filing includes the full acquisition agreement for the Pointe Med Entities, valued at $21.3 million, which is part of the previously announced SPAC merger. These details materially change the risk profile for existing shareholders.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 41% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FCHS was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $273.6K. The 52-week trading range was $0.00 to $0.51. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FCHS - Latest Insights

FCHS
Aug 19, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0093
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Jul 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.012
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
May 08, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0043
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Apr 14, 2026, 1:41 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Mar 27, 2026, 3:12 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info